BALA CYNWYD, Pa., July 24, 2012 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of GenOn Energy, Inc ("GenOn" or the "Company") (NYSE- GEN-News) relating to the proposed acquisition by NRG Energy, Inc. ("NRG").
Under the terms of the transaction, GenOn shareholders would receive only 0.1216 shares of NRG common stock for each share of GenOn stock they own. The transaction values each share of GenOn stock at approximately $2.19 per share. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of GenOn for not acting in the Company's shareholders' best interests in connection with the sale process to NRG.
The transaction may undervalue GenOn as GenOn stock traded at $4.09 per share on July 25, 2011 and $2.62 per share as recently as March 16, 2012. In addition, an analyst has placed a $4.50 price target on the stock. The investigation is also examining potential conflicts of interest as four members of GenOn's Board, including its Chairman and CEO will have continuing positions at the combined company.
If you own shares of GenOn stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at email@example.com visiting http://brodsky-smith.com/458-gen-genon-energy-inc.html, or by calling toll free 877-LEGAL-90.SOURCE Brodsky & Smith, LLC
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV